UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Does Celltrion’s biosimilar have price edge over Roche’s Herceptin?
Competition has been intensifying in the breast cancer therapy market due t...
by Marian Chu
|
2018-05-04 18:15
라인
Janssen Korea gets prostate cancer drug reimbursed as 2nd line therapy
ZYTIGA Janssen Korea said that its prostate cancer therapy ZYTIGA (ingred...
by Marian Chu
|
2018-05-04 17:01
라인
Daewoong compares Nabota with Botox in US, Mexico
Daewoong Pharmaceutical is actively promoting Nabota, an injectable type A ...
by Lee Hye-seon
|
2018-05-04 14:27
라인
AstraZeneca Korea’s antiplatelet therapy gets insurance coverage
AstraZeneca Korea said Thursday that a 60 mg dose of its oral antiplatelet ...
by Marian Chu
|
2018-05-04 11:56
라인
Hanmi posts ₩245.7 billion in Q1 sales
Hanmi Pharmaceutical said Thursday that it recorded 245.7 billion won ($228...
by Lee Han-soo
|
2018-05-03 14:52
라인
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun
|
2018-05-03 14:51
라인
SK Chemicals approves spinoff of its vaccine biz
SK Chemicals said Thursday that the company’s board of directors has approv...
by Lee Han-soo
|
2018-05-03 14:33
라인
Abbvie applies for European marketing approval for investigational psoriasis therapy
Illinois-based pharmaceutical firm Abbvie has submitted a marketing authori...
by Marian Chu
|
2018-05-03 13:12
라인
Roche gets expanded reimbursement for ovarian cancer therapy
Roche Korea (CEO: Matt Sause) said that its targeted therapy Avastin (ingre...
by Marian Chu
|
2018-05-02 18:17
라인
Lilly Korea’s gastric cancer drug gets expanded reimbursement
The Korean branch of Eli Lilly and Company said that its gastric cancer the...
by Marian Chu
|
2018-05-02 17:13
라인
JW Pharma, Syntekabio agree to develop new drugs using AI
JW Pharmaceutical said Wednesday that it has signed a memorandum of underst...
by Lee Han-soo
|
2018-05-02 16:33
라인
Gtree presents dry eye treatment at US conference
Gtree BNT said Wednesday that it has presented data regarding RGN-259, a dr...
by Lee Han-soo
|
2018-05-02 15:37
라인
Bayer’s liver cancer drug gets more reimbursement as 2nd line therapy
Bayer Korea’s targeted liver cancer therapy Stivarga (ingredient: regorafen...
by Marian Chu
|
2018-05-02 15:36
라인
Genexine, Roche to research combination treatment for cancer
Genexine and its U.S. subsidiary NeoImmuneTech said Wednesday they have sig...
by Lee Han-soo
|
2018-05-02 15:13
라인
US court dismisses Medytox’s suit against Daewoong without prejudice
The war of nerves between Daewoong Pharmaceuticals and Medytox over the ori...
by Lee Han-soo
|
2018-04-30 17:31
라인
Korean pharma firms target rare diseases to enter US market
Domestic pharmaceutical companies are targeting the U.S. market with rare d...
by So Jae-hyeon
|
2018-04-30 16:42
라인
LG Chem unveil premium hyaluronic acid filler
LG Chem said Monday that it has released Y-Solution, the company’s premium ...
by Lee Han-soo
|
2018-04-30 15:29
라인
Huons to export BTX to Europe
Huons said Monday that it has signed a contract to export Hutox, its botuli...
by Lee Han-soo
|
2018-04-30 14:14
라인
Top 10 eye-drug revenues rise in 2017
The market for eye disease therapies is becoming hotter as fine dust pollut...
by Nam Doo-hyun
|
2018-04-30 11:31
라인
Huons receives GMP certification in Saudi
Huons said Friday that it has received good manufacturing practice (GMP) ce...
by Lee Han-soo
|
2018-04-27 17:48
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top